急性肾损伤的临床试验：从急性呼吸窘迫综合征网络中吸取的教训。
Clinical Trials for AKI: Lessons Learned From the ARDS Network.
机构信息
Division of Nephrology, Division of Critical Care Medicine, Department of Medicine, Department of Anesthesia, University of California, San Francisco, CA.
出版信息
Semin Nephrol. 2020 Mar;40(2):243-246. doi: 10.1016/j.semnephrol.2020.02.001.
Abstract
The acute respiratory distress syndrome and acute kidney injury are both heterogeneous disease syndromes. A large number of multicenter clinical trials have been conducted focused on the treatment and prevention of the acute respiratory distress syndrome. Here, we focus on potential lessons learned for acute kidney injury clinical trials.
摘要
急性呼吸窘迫综合征和急性肾损伤都是异质性疾病综合征。已经进行了大量的多中心临床试验，专注于治疗和预防急性呼吸窘迫综合征。在这里，我们专注于急性肾损伤临床试验中可能获得的经验教训。
相似文献
1
Clinical Trials for AKI: Lessons Learned From the ARDS Network.急性肾损伤的临床试验：从急性呼吸窘迫综合征网络中吸取的教训。
Semin Nephrol. 2020 Mar;40(2):243-246. doi: 10.1016/j.semnephrol.2020.02.001.
2
Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches.急性呼吸窘迫综合征的预防和治疗的药物治疗：当前和实验方法。
Drugs. 2010 Jul 9;70(10):1255-82. doi: 10.2165/10898570-000000000-00000.
3
Acute Kidney Injury and Acute Respiratory Distress Syndrome.急性肾损伤和急性呼吸窘迫综合征
Crit Care Clin. 2021 Oct;37(4):835-849. doi: 10.1016/j.ccc.2021.05.007. Epub 2021 May 27.
4
Incidence of acute kidney injury and attributive mortality in acute respiratory distress syndrome randomized trials.急性呼吸窘迫综合征随机试验中急性肾损伤的发生率和归因死亡率。
Intensive Care Med. 2024 Aug;50(8):1240-1250. doi: 10.1007/s00134-024-07485-6. Epub 2024 Jun 12.
5
Replacement of albumin by hydroxyethylstarch could increase the risk for acute kidney injury in patients with severe ARDS.用羟乙基淀粉替代白蛋白可能会增加重症急性呼吸窘迫综合征患者急性肾损伤的风险。
Intensive Care Med. 2011 Apr;37(4):719-20. doi: 10.1007/s00134-010-2115-y. Epub 2011 Jan 6.
6
The long-lasting effects of the acute respiratory distress syndrome.急性呼吸窘迫综合征的持久影响。
Expert Rev Respir Med. 2020 Jun;14(6):577-586. doi: 10.1080/17476348.2020.1743182. Epub 2020 Mar 17.
7
Emerging drugs for treating the acute respiratory distress syndrome.治疗急性呼吸窘迫综合征的新兴药物。
Expert Opin Emerg Drugs. 2019 Mar;24(1):29-41. doi: 10.1080/14728214.2019.1591369. Epub 2019 Mar 18.
8
The kidney in acute respiratory distress syndrome: victim or partner in crime?急性呼吸窘迫综合征中的肾脏：受害者还是共犯？
Intensive Care Med. 2024 Aug;50(8):1313-1316. doi: 10.1007/s00134-024-07558-6. Epub 2024 Jul 29.
9
Renal outcomes of intensive care burn patients in an Asian tertiary centre.亚洲一家三级中心重症烧伤患者的肾脏结局。
Burns. 2020 Mar;46(2):400-406. doi: 10.1016/j.burns.2019.07.038. Epub 2019 Aug 23.
10
Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study.治疗性伊洛前列素治疗急性呼吸窘迫综合征（ARDS）（ThIlo 试验）：一项前瞻性、随机、多中心 II 期研究。
Trials. 2020 Mar 4;21(1):242. doi: 10.1186/s13063-020-4163-0.
Zotero 插件